Prognostic Value of Pentraxin-3 Change After Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction
Sheng-Yu Li,1 Lei Liu,1 Ding-Kun Wang,1 Xiao-Song Ding,1 Wei-Ping Li,1,2 Hong-Wei Li1,2 1Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China; 2Beijing Key Laboratory of Metabolic Disorder Related Cardiovas...
Saved in:
Main Authors: | Li SY (Author), Liu L (Author), Wang DK (Author), Ding XS (Author), Li WP (Author), Li HW (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Time Profile of Pentraxin 3 in Patients with Acute ST-Elevation Myocardial Infarction and Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
by: Ragnhild Helseth, et al.
Published: (2014) -
THE RELATIONSHIP OF GENDER WITH IMMEDIATE RESULTS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION
by: N. Netyazhenko, et al.
Published: (2015) -
Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
by: Göksel Çinier, et al.
Published: (2020) -
PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
by: Wu ZF, et al.
Published: (2023) -
Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020)